arenapharmaceuticalsinc.

Is a biopharmaceutical company focused on discovering, developing and commercializing novel drugs that target G protein-coupled receptors (GPCRs) to address unmet medical needs. Devloped APD371, an orally available agonist of the cannabinoid 2 (CB2) receptor, is an internally discovered investigational drug candidate intended for the treatment of pain. They have identified several novel, potent, CB2-selective, lead compounds that are intended to retain the analgesic activity of the CB receptor agonists while avoiding the limiting psychotropic side effects. Stand 21.06.2015

 

WKN: 939027 ISIN: US0400471027 Kürzel: ARNA (OTC)   in  handelbar: JA

 

Gründungsjahr: 1997 Haupthandelsplatz  Vollzogene Namenswechsel:-  Land   Angestellte: 325